Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atlas Venture
Biotech
Triveni raises $92M for I&I pipeline after Modify, Amagma merger
Triveni Bio, the product of a merger between Amagma and Modify, has unveiled with $92 million and a preclinical I&I antibody program.
Gabrielle Masson
Oct 26, 2023 11:27am
Korro Bio merges with off-pitch Frequency, tacks on $117M
Jul 14, 2023 9:50am
Atlas lands $450M fund to build fresh batch of biotechs
Mar 3, 2022 9:10am
Third Harmonic Bio raises $105 million series B
Feb 16, 2022 7:00am
Lilly, Pfizer-backed Arkuda bags $64M to test drug in dementia
Feb 10, 2022 7:00am
Korro Bio rings in new year with $116M for OPERA RNA editing
Jan 5, 2022 7:30am